Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  GPCR & G Protein >  Vasopressin Receptor Antagonists >  Mozavaptan

Mozavaptan

Basic information Safety Supplier Related

Mozavaptan Basic information

Product Name:
Mozavaptan
Synonyms:
  • OPC 31260
  • MOZAVAPTAN
  • 5-(Dimethylamino)-1-[4-(2-methylbenzamido)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
  • Benzamide, N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-
  • -2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)
  • N-(4-(5-(Dimethylamino)
  • CS-134
  • OPC-31260; OPC31260L; OPC 31260
CAS:
137975-06-5
MF:
C27H29N3O2
MW:
427.54
EINECS:
1312995-182-4
Product Categories:
  • Inhibitors
  • Pharmaceutical intermediate
Mol File:
137975-06-5.mol
More
Less

Mozavaptan Chemical Properties

Melting point:
213 - 217°C
Boiling point:
543.0±50.0 °C(Predicted)
Density 
1.21±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
solubility 
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
form 
Solid
pka
13.04±0.70(Predicted)
color 
White to Off-White
More
Less

Mozavaptan Usage And Synthesis

Description

Mozavaptan is an oral vasopressin V2 antagonist that has been launched in Japan for inappropriate antidiuretic hormone secretion syndrome (IADHS), an affliction manifesting as hyponatremia. It joins another nonpeptidic benzazepine, conivaptan, which corrects sodium and water imbalance by blocking the renal V2 receptor resulting in enhanced diuresis, thereby effectively increasing serum sodium concentration. While conivaptan inhibits both V1 and V2 receptors, mozavaptan is significantly more selective for V2 (IC50 of 14nM vs. 1.2 mM for V1).

Originator

Otsuka (Japan)

Uses

Mozavaptan is a vasopressin-receptor antagonist. It is used in the treatment of congestive heart failure and hyponatremia.

Uses

vasopressin V2 receptor antagonist

Definition

ChEBI: Mozavaptan is a member of benzamides.

brand name

Physuline

Synthesis

The reported synthesis of mozavaptan is shown in the scheme. Readily available benzazepin-5-one 39 was refluxed with 40% methyl amine methanol solution in the presence of molecular sieves for 5h followed by the reduction of the resulting imine with sodium borohydride to give the monomethyl amine. Reductive alkylation of the monomethyl amine with formaldehyde in the presence of sodium cyanoborohydride gave the dimethyl amino benzazepine 40. Removal of the tosyl group was facilitated by heating 40 in polyphosphoric acid at 150oC for 2 h to give 41 in 97% yield. Reaction of the resulting benzazepine 41 with p-nitrobenzoyl chloride (42) in the presence of triethylamine provided amide 43 which was hydrogenated in the presence of 10% Pd/C in ethanol at room temperature to give aniline 44. Acylation of aniline 44 with 2-methylbenzoylchloride (45) in the presence of triethylamine gave mozavaptan (VI) in 54% yield.

MozavaptanSupplier

Shanghaizehan biopharma technology co., Ltd. Gold
Tel
021-61350663 13052117465
Email
sales@zehanbiopharma.com
Jiangxi Jinfeng Pharmaceutical Co., Ltd Gold
Tel
793-5181188 18170363299
Email
yangyuening@jxjfpharma.com
Changzhou Chenhong Biotechnology Co., Ltd. Gold
Tel
0519-85788828 13775037613
Email
sales@chemrenpharm.com
Chembest Research Laboratories Limited
Tel
021-20908456
Email
sales@BioChemBest.com
JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Email
sales@jingyan-chemical.com